Anticipated updates on the company’s leukemia drug SLS009 did not land, dampening near-term catalyst momentum. ・Earlier studies showed SLS009 triggered leukemia cell death and remained active in ...

Kate Foster was diagnosed with leukemia at age 12, but she refused to let cancer define her. Now she’s studying to become a doctor, inspired by the medical teams ...

In recognition of AML World Awareness Day, Servier Canada is highlighting the progress made in precision medicine for Acute Myeloid Leukemia (AML).

Following her diagnosis in 2020, the content creator went viral for dancing every day throughout her acute myeloid leukemia ...

Leukemia is a cancer of blood cells that affects the blood, bone marrow, and the lymphatic system. It is a form of cancer ...

Genomic profiling enables therapy individualization when actionable mutations (FLT3, NPM1, IDH1/2, TP53) are present, moving ...

As a Fairhaven first-grader battles a second leukemia diagnosis, a community fundraiser is set to support her family through ...

The Hematology Society of Taiwan yesterday said acute myeloid leukemia (AML), a fast-growing cancer of the blood and bone marrow, can progress quickly and aggressively and urged the government to ...

Emily Taylor said her 7-year-old son Jerett, who goes by Rett, was first diagnosed with T-cell acute lymphoblastic leukemia ...

Kasen Diggs uses his love of golf to battle leukemia. His family is being honored at the American Cancer Society Richmond ...

Last month, the company said that SLS009 blocks key survival pathways that normally shield acute myeloid leukemia cells from natural programmed cell death, making them more vulnerable.

By using CRISPR/Cas9 to engineer cells from healthy donors, AVC-203 is designed to circumvent graft-versus-host disease and host-mediated rejection.